Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 21, 2024 Filed Feb 23, 2024 18:08 UTC
Agrawal VishalChief Strat & Corp Dev Officer
GrantOptions · Derivative 5,257 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004177 · form4.xml · derivative · entry 10

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,257

Underlying: Humana Common · 5,257 shares

Expires 2031-02-21

F7 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F7 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 18:08 UTC
Agrawal VishalChief Strat & Corp Dev Officer
GrantHumana Common 1,362 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004177 · form4.xml · nonDerivative · entry 3

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,248

F11 · shares: Restricted stock units granted to reporting person on 2/21/24.

F12 · balance_after: Includes 1,362 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:54 UTC
Ventura Joseph CChief Legal Officer
GrantOptions · Derivative 6,572 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004170 · form4.xml · derivative · entry 9

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,572

Underlying: Humana Common · 6,572 shares

Expires 2031-02-21

F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:54 UTC
Ventura Joseph CChief Legal Officer
GrantHumana Common 4,425 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004170 · form4.xml · nonDerivative · entry 3

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,453

F10 · shares: Restricted stock units granted to reporting person 2/21/24.

F11 · balance_after: Includes 4,425 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:52 UTC
Huval Timothy S.Chief Administrative Officer
GrantOptions · Derivative 6,309 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004168 · form4.xml · derivative · entry 9

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,309

Underlying: Humana Common · 6,309 shares

Expires 2031-02-21

F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:52 UTC
Huval Timothy S.Chief Administrative Officer
GrantHumana Common 4,357 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004168 · form4.xml · nonDerivative · entry 3

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,747

F10 · shares: Restricted stock units granted to reporting person on 2/21/24.

F11 · balance_after: Includes 4,357 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:09 UTC
Diamond Susan MChief Financial Officer
GrantOptions · Derivative 9,989 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004158 · form4.xml · derivative · entry 9

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,989

Underlying: Humana Common · 9,989 shares

Expires 2031-02-21

F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:09 UTC
Diamond Susan MChief Financial Officer
GrantHumana Common 13,480 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004158 · form4.xml · nonDerivative · entry 3

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,791

F11 · shares: Restricted stock units granted to reporting person on 2/21/24.

F12 · balance_after: Includes 13,480 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:07 UTC
Dintenfass DavidPresident, Enterprise Growth
GrantOptions · Derivative 51,389 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004156 · form4.xml · derivative · entry 2

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,389

Underlying: Humana Common · 51,389 shares

Expires 2031-02-21

F1 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F1 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 17:07 UTC
Dintenfass DavidPresident, Enterprise Growth
GrantHumana Common 13,310 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004156 · form4.xml · nonDerivative · entry 1

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,310

F2 · shares: Restricted stock units granted to reporting person on 2/21/24.

F3 · balance_after: Includes 13,310 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 16:53 UTC
Renaudin George IIPresident, Medicare & Medicaid
GrantOptions · Derivative 6,966 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004154 · form4.xml · derivative · entry 6

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,966

Underlying: Humana Common · 6,966 shares

Expires 2031-02-21

F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 16:53 UTC
Renaudin George IIPresident, Medicare & Medicaid
GrantHumana Common 7,250 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004154 · form4.xml · nonDerivative · entry 3

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,623

F9 · shares: Restricted stock units granted to reporting person on 2/21/24.

F10 · balance_after: Includes 7,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 16:13 UTC
Shetty Sanjay KPresident, CenterWell
GrantOptions · Derivative 6,572 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004149 · form4.xml · derivative · entry 3

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,572

Underlying: Humana Common · 6,572 shares

Expires 2031-02-21

F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 16:13 UTC
Shetty Sanjay KPresident, CenterWell
GrantHumana Common 7,148 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004149 · form4.xml · nonDerivative · entry 1

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,317

F5 · shares: Restricted stock units granted to reporting person on 2/21/24.

F6 · balance_after: Includes 7,148 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 15:37 UTC PurchaseHumana Common 545 $367.09 $200,066.07
Disclosure

SEC source: 0001062993-24-003797 · form4.xml · nonDerivative · entry 1

Mesquita Jorge S. · CIK 0001547344 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,578

F3 · price: Shares acquired through open-market purchase at reported weighted average price.

F1 · balance_after: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24.

F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

F1 · ownership.nature: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24.

F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 16:05 UTC
Rechtin James A.President & COO
GrantRestricted Stock Units · Derivative 6,548 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000737 · form4.xml · derivative · entry 3

Rechtin James A. · CIK 0002006065 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,548

Underlying: Humana Common · 6,548 shares

Expires not disclosed

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.

F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 16:05 UTC
Rechtin James A.President & COO
GrantOptions · Derivative 29,230 $0.00 Strike: $458.19 $0.00
Disclosure

SEC source: 0001062993-24-000737 · form4.xml · derivative · entry 2

Rechtin James A. · CIK 0002006065 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,230

Underlying: Humana Common · 29,230 shares

Expires 2031-01-08

F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27.

F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:46 UTC GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000218 · form4.xml · derivative · entry 4

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:45 UTC GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000216 · form4.xml · derivative · entry 4

Klevorn Marcy S · CIK 0001692367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:20 UTC GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000192 · form4.xml · derivative · entry 5

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 17:19 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000136 · form4.xml · derivative · entry 5

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 17:17 UTC GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000134 · form4.xml · derivative · entry 5

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 16:45 UTC GrantHumana Common 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000130 · form4.xml · nonDerivative · entry 1

Mesquita Jorge S. · CIK 0001547344 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,033

F1 · balance_after: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24.

F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

F1 · ownership.nature: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24.

F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 16:22 UTC GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000128 · form4.xml · derivative · entry 5

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 16:20 UTC GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000126 · form4.xml · derivative · entry 4

Bono Raquel C. · CIK 0001823759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 16:03 UTC GrantHumana Common 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000120 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,685

F3 · balance_after: Includes 430 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 15:12 UTC
KATZ KARENDirector
GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000110 · form4.xml · derivative · entry 5

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 14:56 UTC GrantRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-000108 · form4.xml · derivative · entry 5

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 21:46 UTC GrantRestricted Stock Units · Derivative 9 $456.91 $4,112.22
Disclosure

SEC source: 0001062993-24-000218 · form4.xml · derivative · entry 3

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15

Underlying: Humana Common · 9 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 21:45 UTC GrantRestricted Stock Units · Derivative 6 $456.91 $2,741.48
Disclosure

SEC source: 0001062993-24-000216 · form4.xml · derivative · entry 3

Klevorn Marcy S · CIK 0001692367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8

Underlying: Humana Common · 6 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 21:20 UTC GrantRestricted Stock Units · Derivative 3 $456.91 $1,370.74
Disclosure

SEC source: 0001062993-24-000192 · form4.xml · derivative · entry 4

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3

Underlying: Humana Common · 3 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 21:20 UTC GrantRestricted Stock Units · Derivative 40 $456.91 $18,276.53
Disclosure

SEC source: 0001062993-24-000192 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141

Underlying: Humana Common · 40 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 17:19 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 3 $456.91 $1,370.74
Disclosure

SEC source: 0001062993-24-000136 · form4.xml · derivative · entry 4

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3

Underlying: Humana Common · 3 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 17:19 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 71 $456.91 $32,440.84
Disclosure

SEC source: 0001062993-24-000136 · form4.xml · derivative · entry 3

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262

Underlying: Humana Common · 71 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 17:17 UTC GrantRestricted Stock Units · Derivative 211 $456.91 $96,408.69
Disclosure

SEC source: 0001062993-24-000134 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,816

Underlying: Humana Common · 211 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 17:17 UTC GrantRestricted Stock Units · Derivative 304 $456.91 $138,901.61
Disclosure

SEC source: 0001062993-24-000134 · form4.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,188

Underlying: Humana Common · 304 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 16:22 UTC GrantRestricted Stock Units · Derivative 257 $456.91 $117,426.69
Disclosure

SEC source: 0001062993-24-000128 · form4.xml · derivative · entry 4

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,123

Underlying: Humana Common · 257 shares

Expires not disclosed

F4 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F4 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F4 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F4 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 16:20 UTC GrantRestricted Stock Units · Derivative 9 $456.91 $4,112.22
Disclosure

SEC source: 0001062993-24-000126 · form4.xml · derivative · entry 3

Bono Raquel C. · CIK 0001823759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15

Underlying: Humana Common · 9 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 16:03 UTC GrantRestricted Stock Units · Derivative 2 $456.91 $913.83
Disclosure

SEC source: 0001062993-24-000120 · form4.xml · derivative · entry 3

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2

Underlying: Humana Common · 2 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2023 Filed Jan 3, 2024 15:12 UTC
KATZ KARENDirector
GrantRestricted Stock Units · Derivative 17 $456.91 $7,767.52
Disclosure

SEC source: 0001062993-24-000110 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37

Underlying: Humana Common · 17 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 588 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · derivative · entry 15

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,176

Underlying: Humana Common · 588 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 512 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · derivative · entry 14

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 512

Underlying: Humana Common · 512 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 367 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · derivative · entry 12

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 367 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 274 $463.58 $127,020.92
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 6

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,080

F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Restricted Stock Units on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 588 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 5

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 239 $463.58 $110,795.62
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 4

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,766

F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Restricted Stock Units on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 512 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 3

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,005

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 171 $463.58 $79,272.18
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 2

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,493

F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Restricted Stock Units on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:08 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 367 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 1

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:00 UTC
Deshpande SamirChief Information Officer
Exercise / conversionRestricted Stock Units · Derivative 334 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022815 · form4.xml · derivative · entry 13

Deshpande Samir · CIK 0001712481 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 670

Underlying: Humana Common · 334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.